Spiritus Biosciences is focused on improving patient experience by contouring drug delivery and patient experience with novel formulation and final form technology.
Our experienced team of formulation scientists and drug delivery specialists, in collaboration with leading research laboratories, are creating a pipeline of defensibly patentable drug delivery products to address unmet needs in mental health and for neuropsychiatric disorders.
Spiritus is about to begin providing our proprietary, patented, and ground-breaking method of delivery in Phase I and II trials. Our unique clinical trial design enables the collection of data in significantly less time and lower cost than has previously been possible.
Our goal is simple: improve existing strategies of drug delivery to support safer and more efficient treatment with less adverse effects for some of the most pressing mental health issues of our time.